POET-II Trial Reassesses Antibiotic Duration for Infective Endocarditis

The POET-II trial investigates the optimal duration of antibiotic therapy for left-sided infective endocarditis (IE), a serious but uncommon disease affecting the aortic or mitral valves. The study aims to improve treatment outcomes by re-evaluating current antibiotic regimens, potentially reducing therapy length while maintaining effectiveness against this high-morbidity condition.

Tip: use ↑ / ↓ (or j / k) to move between stories.